Status:
NOT_YET_RECRUITING
Cardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize
Lead Sponsor:
Assiut University
Conditions:
Diabete Mellitus
Eligibility:
All Genders
40+ years
Brief Summary
calculate cardiovascular risk scores in type 2 DM patients, then estimate its association with new visceral adipose tissue indices
Detailed Description
Cardiovascular disease (CVD) constitutes a significant health challenge for individuals with type 2 diabetes mellitus (T2DM), affecting approximately 32% of this population and contributing significan...
Eligibility Criteria
Inclusion
- Adult patients ≥40 years old attending the out patients clinics
- Patients diagnosed with type 2 diabetes mellitus
Exclusion
- Patient with a history of cardiovascular events
- Patient with type 1 diabetes or gestational diabetes.
- Pregnant women.
- Hypothyroidism,
- Cushing disease
- polycystic ovarian syndrome.
- Congestive heart failure
- chronic liver disease
- .- chronic kidney disease,
- cancer
- Current use of steroids, birth control pills, antipsychotics, antidepressants, epilepsy drugs.
- Patients with physical deformities or conditions affecting anthropometric measurements.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
238 Patients enrolled
Trial Details
Trial ID
NCT07204782
Start Date
December 1 2025
End Date
July 1 2027
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt